glp 1 drugs companies Food are targeting users of weight-loss with 'GLP-1 Friendly' labels GLP-1 Medications for Weight Loss:

A recent study showed that subtype 1b remained the most prevalent and widely distributed genotype in China (35)

Long-term human safety data does not exist

DSIP is primarily utilized as a neuropeptide research tool

J Natl Cancer Inst 63, 84954

Key unknowns include: Long-term effects of repeated GH-axis stimulation Effects of sustained IGF-1 elevation Effects on glucose metabolism and insulin sensitivity Cardiovascular effects in higher-risk populations Immunogenicity after repeated exposure Differences between DAC and No DAC safety profiles Safety of non-pharmaceutical or poorly characterized peptide sources Why it matters: Short-term tolerability does not equal long-term safety